Lilly gets FDA nod on new osteoporosis drug use
Eli Lilly & Co said Friday that it had won approval to marketits blockbuster osteoporosis drug to post-menopausal women who areat high risk for invasive breast cancer.
More... |
All times are GMT -7. The time now is 05:25 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021